Domoxin (INN) is a hydrazine derivative monoamine oxidase inhibitor (MAOI) antidepressant which was never marketed.
List of articles in "Drug" category - Page 37
Cimemoxin
Cimemoxin (INN) or cyclohexylmethylhydrazine is a hydrazine derivative monoamine oxidase inhibitor (MAOI) antidepressant which was never marketed.
Buthalital
Buthalital sodium (INN; Bayinal Baytinal Thialbutal Transithal Ulbreval) or buthalitone sodium (BAN) is a barbiturate derivative which was under development as a short-acting anesthetic. However development was discontinued perhaps due […]
Propylbarbital
Propylbarbital (Propal Propanal Proponal) also known as 55-dipropylbarbituric acid is a barbiturate derivative used as a hypnotic drug.
Methitural
Methitural (INN; Neraval Thiogenal) or methitural sodium also known as methioturiate is a barbiturate derivative which was marketed in the 1950s in Europe (in Germany and Italy) as an ultra-short-acting […]
Tofenacin
Tofenacin (INN; Elamol Tofacine Tofalin) or tofenacin hydrochloride (USAN) also sometimes called mono-N-desmethylorphenadrine is an antidepressant drug with a tricyclic-like structure which was developed and marketed in the United Kingdom […]
Omiloxetine
Omiloxetine (INN) is an antidepressant with a similar chemical structure to that of paroxetine which either was or is still under development by Ferrer Internacional for the treatment of major […]
L-Norpseudoephedrine
L-Norpseudoephedrine or (-)-norpseudoephedrine also referable to as (-)-threo-β-hydroxyamphetamine is a psychostimulant drug of the amphetamine family. It is one of the four optical isomers of phenylpropanolamine the other three being […]
Pseudophenmetrazine
Pseudophenmetrazine is a psychostimulant compound of the morpholine class. It is the N-demethylated and cis-configured analogue of phendimetrazine as well as the cis-configured stereoisomer of phenmetrazine. In addition along with […]
Iomazenil
Iomazenil (also known as Ro16-0154 INN USAN; benzodine) is an antagonist and partial inverse agonist of benzodiazepine and a potential treatment for alcohol abuse. The compound was introduced in 1989 […]